Filing Analysis
Officer Departure
Filed Apr 23, 2026
LOW
On April 17, 2026, Ana Hooker resigned from Exagen Inc.'s Board of Directors and its committees. The company subsequently reduced its board size from eight to seven members and reconstituted its standing committees.
Key Facts
- Ana Hooker resigned as a director effective April 17, 2026.
- Ms. Hooker served as the chair of the Nominating and Corporate Governance Committee and was a member of the Audit Committee.
- The resignation was not due to any disagreement with the company's operations, policies, or practices.
- The Board of Directors' size was reduced from eight to seven members following the resignation.
- The company announced the new composition of the Audit, Compensation, and Nominating and Corporate Governance committees.
Regulation FD Disclosure
Filed Mar 10, 2026
LOW
Exagen Inc. reported its financial results for the fourth quarter and fiscal year ended December 31, 2025, via a press release furnished with the SEC.
Key Facts
- Financial results for Q4 and FY 2025 reported on March 10, 2026
- Information furnished under Item 2.02 (Results of Operations and Financial Condition)
- Exhibit 99.1 contains the full press release
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.